Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Clinical trial NCT05755854 · UNKNOWN

Trial details

NCT number: NCT05755854
Sponsor: Anhui Provincial Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Diseases

Start date: 2023-05-03
Primary completion: 2024-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.